These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7818818)

  • 1. HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch.
    Lehman JS; Allen DM; Green TA; Onorato IM
    AIDS; 1994 Oct; 8(10):1465-9. PubMed ID: 7818818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992.
    Weinstock HS; Sidhu J; Gwinn M; Karon J; Petersen LR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):514-22. PubMed ID: 7627627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising HIV infection rates in Ho Chi Minh City herald emerging AIDS epidemic in Vietnam.
    Lindan CP; Lieu TX; Giang LT; Lap VD; Thuc NV; Thinh T; Lurie P; Mandel JS
    AIDS; 1997 Sep; 11 Suppl 1():S5-13. PubMed ID: 9376101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV prevalence among Surinam and Antillean drug users in Amsterdam].
    Fennema JS; van den Hoek JA; Huisman JG; Coutinho RA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2209-13. PubMed ID: 8247167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV seroprevalence surveys in drug treatment centers.
    Jones TS; Allen DM; Onorato IM; Petersen LR; Dondero TJ; Pappaioanou M
    Public Health Rep; 1990; 105(2):125-30. PubMed ID: 2108456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach.
    Weiss SH; Weston CB; Quirinale J
    AIDS Educ Prev; 1993; 5(4):279-93. PubMed ID: 8297708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel surveillance of human immunodeficiency virus infection in women seeking reproductive health services in the United States, 1988-1989. The Field Services Branch.
    Sweeney PA; Onorato IM; Allen DM; Byers RH
    Obstet Gynecol; 1992 Apr; 79(4):503-10. PubMed ID: 1553166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV seroprevalence surveys in sexually transmitted disease clinics.
    Onorato IM; McCray E; Pappaioanou M; Johnson R; Aral S; Hardy AM; Dondero TJ
    Public Health Rep; 1990; 105(2):119-24. PubMed ID: 2108455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlinked anonymous monitoring of human immunodeficiency virus prevalence in high- and low-risk groups in Slovenia, 1993-2002.
    Klavs I; Poljak M
    Croat Med J; 2003 Oct; 44(5):545-9. PubMed ID: 14515410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.
    Alary M; Joly JR; Parent R; Fauvel M; Dionne M
    CMAJ; 1994 Oct; 151(7):975-81. PubMed ID: 7922933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Condom use and HIV risk behaviors among U.S. adults: data from a national survey.
    Anderson JE; Wilson R; Doll L; Jones TS; Barker P
    Fam Plann Perspect; 1999; 31(1):24-8. PubMed ID: 10029929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Iranian women seeking drug treatment.
    Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A
    J Womens Health (Larchmt); 2011 Nov; 20(11):1687-91. PubMed ID: 21905877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the HIV risk reduction intervention for women entering inpatient substance abuse treatment.
    Eldridge GD; St Lawrence JS; Little CE; Shelby MC; Brasfield TL; Service JW; Sly K
    AIDS Educ Prev; 1997 Feb; 9(1 Suppl):62-76. PubMed ID: 9083599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of HIV infection in Italian drug users attending drug treatment centers in the years 1990-92].
    Rezza G; Alliegro MB; De Rose A; Pezzotti P; Serafin I
    Ann Ist Super Sanita; 1995; 31(3):301-5. PubMed ID: 8712572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of HIV-1 infection in Peru, 1986-1990.
    McCarthy MC; Wignall FS; Sanchez J; Gotuzzo E; Alarcon J; Phillips I; Watts DM; Hyams KC
    AIDS; 1996 Sep; 10(10):1141-5. PubMed ID: 8874632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.